[4] It is important to distinguish pancreatitis from the common gastrointestinal side effects that affect many semaglutide users, particularly during dose escalation
Please review package insert (if available) for further information
Tirzepatide, at both doses, led to significant reductions in bodyweight compared to placebo at week 72
This matters for this comparison because Ros published Ro Body Program materials reference 15% average body weight reduction at week 68 a figure from the STEP clinical trial program, which studied branded Wegovy, not compounded semaglutide
If you have been struggling to lose weight, one of our transformative weight loss treatments may help you achieve the results you desire
This combination is suitable for individuals with increased nutritional needs, physically active adults, and those recovering from illness or experiencing fatigue